Company / Current Assets
SELLAS Life Sciences Group, Inc. Current Assets History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$16.3M
FY2024
5-year range
$3.2M / $36.9M
FY2020-FY2024
Trend
+414.7%
vs FY2023
Sector context
#210 of 213
Health Care
What the data says
Current Assets changed +415% YoY in FY2024, a notable deviation from the 9-year average annual change of +69%.
Based on SEC 10-K filings.
$16M in FY2024 with a 5-year CAGR of +14.7%.
Declined from $18M to $16M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- -10.9%
- 5-Year CAGR
- +14.7%
- 10-Year CAGR
- -
Sector benchmark
Bottom 1% in Health CareTop 99% of 213This company $16.3M Sector average $2.5B
▼
-99.4% below sector average
Key checks
Key Insights
- 5-year CAGR of +14.7%, indicating consistent growth.
- In FY2024, current assets increased 414.7% year-over-year.
- Ranks #210 out of 213 companies in the Health Care sector.
- Peak current assets was recorded in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.39 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $16.3M | +414.7% |
| FY2023 | $3.2M | -82.1% |
| FY2022 | $17.8M | -22.9% |
| FY2021 | $23.0M | -37.6% |
| FY2020 | $36.9M | +348.0% |
| FY2019 | $8.2M | +41.2% |
| FY2018 | $5.8M | -55.4% |
| FY2017 | $13.1M | +105.2% |
| FY2016 | $6.4M | -88.1% |
| FY2015 | $53.6M | +2.9% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026